Final Glance: Pharmaceuticals companies
AP - 2 hrs 10 mins ago
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 100.43 (+0.13), BAX: 70.38 (+0.33), PFE: 34.93 (+0.04), BMY: 66.60 (-0.21)
Pfizer's Cancer Drug Meets First Primary Endpoint in Phase III - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 26 mins ago
Pfizer Inc.'s (PFE) phase III study on inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia (ALL) met the first primary endpoint.
BIIB: 423.57 (+1.46), PFE: 34.93 (+0.04), HZNP: 30.96 (+0.10), AMGN: 169.10 (+0.64)
Beat The Market Twice: 5 Top Dividend Stock Winners
at Investor's Business Daily - Wed Apr 22, 4:24PM CDT
Dividend-paying companies aren't usually known for their stock price performance, but these five Dividend Leaders are beating the market this year -- and offer big yields, too. All have bagged double-digit gains, compared with about a 6% advance for...
RAI: 76.04 (+0.43), UN: 44.06 (-0.59), WU: 20.80 (+0.10), PFE: 34.93 (+0.04), LO: 70.77 (-0.23), MSFT: 42.99 (+0.36), AAPL: 128.62 (+1.71)
Midday Glance: Pharmaceuticals companies
AP - Wed Apr 22, 12:39PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 100.43 (+0.13), BAX: 70.38 (+0.33), PFE: 34.93 (+0.04), BMY: 66.60 (-0.21)
Capricor cell therapy candidate an Orphan Drug for Duchenne muscular dystrophy
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 11:56AM CDT
ROSG: 3.83 (-0.20), CAPR: 7.50 (+0.76), BMRN: 121.08 (-0.16), RNA: 18.65 (unch), PFE: 34.93 (+0.04), SRPT: 13.52 (+0.04), PTCT: 70.98 (unch), SMMT: 11.00 (-0.59)
Pfenex Inc. Shifts Focus In-House To Develop Biosimilar To Betaseron
Christopher Stoehr - at Seeking Alpha - Wed Apr 22, 11:10AM CDT
PFE: 34.93 (+0.04), PFNX: 15.12 (+0.42), HSP: 87.80 (+0.04)
Uptrend Call Working As Pfizer Stock Rises 17.5% (PFE)
Comtex SmarTrend(R) - Wed Apr 22, 9:59AM CDT
SmarTrend identified an Uptrend for Pfizer (NYSE
PFE: 34.93 (+0.04)
Early Glance: Pharmaceuticals companies
AP - Wed Apr 22, 9:25AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 100.43 (+0.13), BAX: 70.38 (+0.33), PFE: 34.93 (+0.04), BMY: 66.60 (-0.21)
A Discussion Of Amgen's Q1 Results, With Updates On Its Pipeline
DoctoRx - at Seeking Alpha - Wed Apr 22, 8:28AM CDT
PFE: 34.93 (+0.04), AMGN: 169.10 (+0.64), LLY: 72.30 (+0.09), BMY: 66.60 (-0.21), SNY: 51.59 (+0.03), REGN: 472.63 (+9.41), HSP: 87.80 (+0.04), CELG: 115.54 (+0.72)
Is Immuno-Oncology the Best Area of Biotech to Invest in Right Now?
George Budwell, The Motley Fool - Motley Fool - Wed Apr 22, 7:11AM CDT
Biotechnology is rapidly giving rise to ground-breaking new medicines that are dramatically changing the outlook for devastating diseases such as hepatitis C, malaria, and, perhaps most astoundingly, cancer. This innovation boom has gone hand in hand...
AGEN: 6.08 (+0.21), ADXS: 22.18 (+0.10), PFE: 34.93 (+0.04), MRK: 57.69 (+0.03), AZN: 73.35 (+0.65), BMY: 66.60 (-0.21), FPRX: 24.07 (-0.85)
Healthcare's Health Scanner: Complementary Research on Pfizer, Mylan, Teva Pharmaceutical, Bristol-Myers Squibb, and Merck & Company
PR Newswire - Wed Apr 22, 7:00AM CDT
Editor Note: For more information about this release, please scroll to bottom.
MRK: 57.69 (+0.03), PFE: 34.93 (+0.04), MYL: 72.40 (-1.67), TEVA: 63.01 (-1.15), BMY: 66.60 (-0.21)
Most active New York Stock Exchange-traded stocks
AP - Tue Apr 21, 5:03PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
T: 32.86 (+0.20), GE: 26.91 (+0.29), AA: 13.57 (+0.05), RF: 9.73 (+0.15), CHK: 14.41 (-0.16), PFE: 34.93 (+0.04), C: 53.10 (+0.62), HAL: 47.11 (+0.06), BAC: 15.74 (+0.24), CSX: 36.26 (+0.91), VZ: 49.57 (+0.40), RAD: 8.32 (+0.39)
Merck KGaA-Pfizer Start First Cancer Registration Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 3:50PM CDT
Merck KGaA (MKGAF) and Pfizer Inc. (PFE) announced the commencement of a phase III study on avelumab in comparison with Taxotere for non-small cell lung cancer.
SHPG: 253.58 (+3.70), PFE: 34.93 (+0.04), HZNP: 30.96 (+0.10)
Pharma Spends Big On M&A In Q1 As Teva Pulls Trigger On Mylan
EP Vantage - Seeking Alpha - Tue Apr 21, 2:25PM CDT
The pharma and biotech buying spree showed no sign of abating in the opening months of 2015, with $69bn committed across 62 deals in the first quarter, EvaluatePharma data show. And with Teva (NYSE: TEVA ) confirming its interest in ...
AGN: 240.22 (+2.88), VRX: 206.93 (-3.92), ACT: 295.22 (+0.69), PFE: 34.93 (+0.04), MYL: 72.40 (-1.67), ABBV: 64.52 (+0.91), TEVA: 63.01 (-1.15)
Pfizer says leukemia drug met 1 goal in study
AP - Tue Apr 21, 11:06AM CDT
NEW YORK (AP) — Pfizer said Tuesday that an experimental blood cancer drug met one of its two goals in a late-stage trial, as patients who were treated with the drug were more likely to have a complete remission.
PFE: 34.93 (+0.04)
Pfizer's Xalkori tagged a Breakthrough Therapy for type of lung cancer
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 9:38AM CDT
PFE: 34.93 (+0.04)